Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

3,287.85INR
14 Aug 2018
Change (% chg)

Rs20.75 (+0.64%)
Prev Close
Rs3,267.10
Open
Rs3,275.00
Day's High
Rs3,295.00
Day's Low
Rs3,260.10
Volume
6,824
Avg. Vol
16,030
52-wk High
Rs3,339.95
52-wk Low
Rs2,020.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform -- March 16 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 3 3 3
(4) UNDERPERFORM 6 6 6 6
(5) SELL 1 0 1 1
No Opinion 0 0 0 0
Mean Rating 3.55 3.36 3.50 3.50

Consensus Estimates Analysis

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 1 8,215.00 8,215.00 8,215.00 --
Year Ending Mar-18 9 30,763.50 32,896.20 29,140.00 --
Year Ending Mar-19 9 33,235.00 37,704.90 31,873.00 36,326.00
Year Ending Mar-20 8 36,746.40 39,698.00 34,643.00 39,335.00
Earnings (per share)
Year Ending Mar-18 9 42.32 49.10 37.49 --
Year Ending Mar-19 9 52.29 61.30 45.06 52.19
Year Ending Mar-20 8 61.54 69.40 50.42 58.16

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in India Rupee (INR)
Earnings and Dividend Figures in India Rupee (INR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 8,215.00 -- -- -- --
Year Ending Mar-18 30,763.50 -- -- -- --
Year Ending Mar-19 33,235.00 33,235.00 33,260.40 33,399.60 36,326.00
Year Ending Mar-20 36,746.40 36,746.40 36,740.80 37,040.40 39,335.00
Earnings (per share)
Year Ending Mar-18 42.32 -- -- -- --
Year Ending Mar-19 52.29 52.29 50.97 51.71 52.19
Year Ending Mar-20 61.54 61.54 59.19 60.44 58.16

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 -- -- -- --
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 1 1
Year Ending Mar-20 0 0 1 1
Earnings
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 2 1
Year Ending Mar-20 0 0 3 0